Pharma-Bio Serv, Inc. (PBSV): Results of Operations and Financial Condition
Pharma-Bio Serv, Inc. (PBSV) filed an SEC Form 8-K — Results of Operations and Financial Condition. pbsv_8k.htm 0001304161 false 0001304161 2026-06-15 2026-06-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 D
How this was made
The 30-second read
Why it matters
The filing is a formal disclosure vehicle; however, the provided text does not include the actual financial results or any guidance, limiting the ability to infer market impact from this excerpt alone.
Market read
Traders can treat this as the start of the earnings-information window, but must read Exhibit 99.1 to assess whether the quarter/guidance is a catalyst.
What to watch
Traders should verify Exhibit 99.1 for any surprises (revenue, net income/loss, liquidity/cash, debt, or forward-looking statements) that could change valuation expectations.
Background
The article is an SEC Form 8-K (Item 2.02) stating the company issued a press release with quarterly results for the quarter ended April 30, 2026.
Ticker impact
The SEC 8-K states Pharma-Bio Serv issued a press release with results for the quarter ended April 30, 2026 (Exhibit 99.1).
Likely limited immediate impact from the excerpt alone; any tradable move would depend on the missing Exhibit 99.1 figures and commentary.
The body confirms the existence of the results press release but does not provide the actual financial metrics, guidance, or management commentary needed to forecast price reaction.
Market effects
No sector read-across is provided; this is company-specific filing boilerplate plus a reference to Exhibit 99.1.
None indicated.
None indicated.
Counterpoint
Because the excerpt omits Exhibit 99.1, the market reaction could be driven by details not shown here (e.g., margin, cash burn, or guidance).
Key entities
- issuerPharma-Bio Serv, Inc.
Registrant filing the 8-K and furnishing quarterly results press release as Exhibit 99.1.
- regulatory_filingSEC Form 8-K
Current report under Item 2.02 (Results of Operations and Financial Condition).
- exhibitExhibit 99.1
Press release dated June 15, 2026 containing the quarterly results (not included in the excerpt).
